Oragenics awards stock options to executives; reschedules annual meeting to Dec 11, 2024

ORAGENICS INC

Compensation Committee approved immediate-vesting stock options: 100k shares to President Redmond, 80k to CFO Huffman.
Options granted under 2021 Equity Incentive Plan; vest immediately upon grant.
2023 Annual Meeting rescheduled to December 11, 2024; shareholder proposals due October 20, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.